has found resistance at the $4.00 mark multiple times in recent days. With a combination of consolidation and the narrowing of support -- ROSG
is poised to make a breakout to either the upside or downside. Based on a support from $3.88 to $3.92 and an upside potential of ~$4.20, there is a larger upside than downside. Additionally this company has 2 new bladder cancer assays being commercially introduced during the American Urological Association's (AUA) annual meeting running from May 15th to May 19th; suggesting that news will be released soon about how the products faired during the meeting.
Note that buying any stock carries with it uncertainty. Buy at your own risk.